full report - UCT - Research Report 2011

esearCH fielDs anD staff
All staff members are involved in data collection
Dr Kate Balme is responsible for case data on poisoning.
ContaCt Details
Postal Address: Poisons Information Centre, School
of Child and Adolescent Health, University of Cape
Town, Red Cross Children’s Hospital, Klipfontein Rd,
Rondebosch, 7700
Tel: +27 21 658 5308
Fax: +27 21 658 5331
Email poisonsinformation@uct.ac.za
soUtH afriCan tUberCUlosis
vaCCine initiative (satvi)
HeaD of Unit: professor WilleM HanekoM
The mission of the South African TB Vaccine Initiative
(SATVI) is to develop TB vaccines that would impact on
the world-wide epidemic. This large research division
accommodates several disciplines including paediatrics,
infectious diseases, epidemiology, public health,
immunology and clinical/biological sciences. SATVI has
a large and well-developed clinical field site in the Boland
Overberg region, with the core on the premises of the
Brewelskloof TB Hospital in Worcester; most clinical/
epidemiological studies and clinical trials of new TB
vaccines are conduced from here. SATVI’s state-of-the-art,
SANAS accredited immunology laboratories are housed in
the Institute of Infectious Diseases and Molecular Medicine
at the Faculty of Health Sciences, with a smaller lab at the
field site. The common goal of research activities is to
better understand the clinical and biological aspects of TB
in order to facilitate TB vaccine development. To this end,
SATVI has already completed early phase clinical trials of
four novel TB vaccines and is conducting proof-of-concept
phase IIb trials of the two most clinically advanced TB
vaccines in infants. SATVI is actively involved in training
of staff, postgraduate students, and postdoctoral fellows
and is very active internationally in driving best practices
for conducting TB vaccine trials. The division has one of
the highest income from research awards in the University
and generates a large number of outputs, as measured by
accredited publications. Divisional leaders are represented
on international bodies that guide policy and research in
TB vaccines.
FaCULTY oF heaLTh sCienCes
students and postdoctoral fellows
Master’s 5
phD 5
postdoctoral fellows 3
total 13
staff
permanent staff (full time) 157
permanent staff (part time) 1
total 158
researCH fielDs anD staff
Research staff
WilleM HanekoM
TB vaccine development and testing; Correlates of risk of
TB in infants and adolescents; Immunopathogenesis of TB
in infants, adolescents and adults.
Hassan MaHoMeD
TB vaccine development and testing; Epidemiology and
diagnosis of TB in infants and adolescents.
Mark HatHerill
Epidemiology and diagnosis of TB in infants and
adolescents; TB vaccine testing in infants of HIV infected
mothers.
Hennie gelDenHUys
TB vaccine development and testing; Epidemiology and
diagnosis of TB in infants and adolescents.
MiCHele taMeris
TB vaccine development and testing; Epidemiology and
diagnosis of TB in infants and adolescents.
angeliQUe kany kany lUabeya
TB vaccine development and testing; Epidemiology and
diagnosis of TB in infants and adolescents.
CHeryl Day
TB vaccine development and testing; Immunopathogenesis
of TB in infants, adolescents and adults.
tHoMas sCriba
TB vaccine development and testing; Correlates of risk of
TB in infants and adolescents; Immunopathogenesis of TB
in infants, adolescents and adults.
257